Aldesleukin Recruiting Phase 2 Trials for Metastatic Melanoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03850691Radiation and Combination Immunotherapy for Melanoma